J HEPATOL 润色咨询

JOURNAL OF HEPATOLOGY

出版年份:暂无数据 年文章数:2346 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:6.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2022-12-30 ms5000001189510088 来自四川省

    想问问这个杂志收中药单体的机制研究文章吗?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2023-07-20 121d577cm33(暂无昵称) 来自上海

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:肝癌
    经验分享:with editor 1周,10号送外审,期待中

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2023-05-21 1ddf3775m09(暂无匿称) 来自上海

    请问投稿后一般with editor几天会送审?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2022-08-25 121ec805m86(暂无昵称)

    With Editor 一个周了,不知道会怎么样

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2015-10-09 lss7259

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2017-09-02 1dd96cb3m86(暂无匿称)

    第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2020-03-24 cpufanfan

    感觉好慢呀。under review状态都变了三次了。不知道什么情况。186****1268 2020-03-22 00:00:00 发表:
    那应该是送外审了,祝好运

    186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-10-16 心内一科

    审稿速度:2.0
    偏重的研究方向:临床转化;基础研究
    经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-12-24 122766cam31(暂无昵称)

    请问二审一般多久

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2108161, encodeId=2f0821081610e, content=想问问这个杂志收中药单体的机制研究文章吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea225571309, createdName=ms5000001189510088, createdTime=Fri Dec 30 17:16:04 CST 2022, time=2022-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2149050, encodeId=618b214905096, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:肝癌<br>经验分享:with editor 1周,10号送外审,期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ephyuqAymtlDMRohLN2uuz46RrlziauJLvAbftD6K7tvs9bP6BDQuWkA1v323SR995RqtibaobUd3tA/132, createdBy=8a742285606, createdName=121d577cm33(暂无昵称), createdTime=Thu Jul 20 19:22:03 CST 2023, time=2023-07-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138167, encodeId=7d8a213816eae, content=请问投稿后一般with editor几天会送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/2c35a2a30a744be1ae1bf73f9aed6914/c61b34f65a0049d0a7fe43196800d807.jpg, createdBy=a6891663153, createdName=1ddf3775m09(暂无匿称), createdTime=Sun May 21 12:25:43 CST 2023, time=2023-05-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1240992, encodeId=adf712409924e, content=With Editor 一个周了,不知道会怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67bf2292629, createdName=121ec805m86(暂无昵称), createdTime=Thu Aug 25 18:03:10 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515810, encodeId=628d51581005, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:投稿后20天拒搞,给机会再投(状态为revised),两个reviewer提了一堆问题,因为问题比较多当时挺担心的。前后花了4个月时间补实验,并照审稿人意见逐条修改,认真回答。修回后1个月状态变为accept-with minor revise,按照review意见进行修改后10接收。从投到接收共6个多月,杂志速度挺快,主要是自己等小鼠补实验花费了两三个月时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=458, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77d21654857, createdName=lss7259, createdTime=Fri Oct 09 13:09:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546222, encodeId=aec854622249, content=第一次投稿的时候三天就拒绝了.这次投稿.在副主编里with editor8天了.好担心.希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=576, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Sat Sep 02 16:33:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587302, encodeId=c66158e302d9, content=感觉好慢呀。under review状态都变了三次了。不知道什么情况。<span class="quote">186****1268 2020-03-22 00:00:00 发表:<br>那应该是送外审了,祝好运</span>, beContent=186****1268 2020-03-22 00:00:00 发表: 那应该是送外审了,祝好运, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200709/0f27fd1aef80482ea0f83a6fa7781324/3dd7506f6bfd4983a69ad1f8da6d58f7.jpg, createdBy=e9415194902, createdName=cpufanfan, createdTime=Tue Mar 24 00:00:00 CST 2020, time=2020-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061122, encodeId=4a7f10611226d, content=审稿速度:2.0<br>偏重的研究方向:临床转化;基础研究<br>经验分享:肝病领域的权威杂志,可惜被某李姓长江玩坏了。整天在上面卖NASH和肝I/R的文章,还都是一个套路。都是些NF-kb通路、ASK1/P38通路和GSK3通路,流水线生产的假文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=36db2019043, createdName=心内一科, createdTime=Sat Oct 16 22:36:00 CST 2021, time=2021-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083851, encodeId=302010838515c, content=请问二审一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f58f2333687, createdName=122766cam31(暂无昵称), createdTime=Fri Dec 24 11:06:15 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011764, encodeId=db4e1011e64ca, content=请问一审周期多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c2cd2483735, createdName=12463b17m04(暂无昵称), createdTime=Thu Aug 26 18:01:15 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-26 12463b17m04(暂无昵称)

    请问一审周期多久呀

    0

共64条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分